EVOLENT HEALTH INC - A (EVH) Fundamental Analysis & Valuation

NYSE:EVH • US30050B1017

Current stock price

2.33 USD
-0.11 (-4.51%)
At close:
2.3435 USD
+0.01 (+0.58%)
After Hours:

This EVH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EVH Profitability Analysis

1.1 Basic Checks

  • EVH had positive earnings in the past year.
  • In the past year EVH had a positive cash flow from operations.
  • EVH had negative earnings in each of the past 5 years.
  • Of the past 5 years EVH 4 years had a positive operating cash flow.
EVH Yearly Net Income VS EBIT VS OCF VS FCFEVH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • EVH has a Return On Assets (-30.51%) which is in line with its industry peers.
  • EVH has a worse Return On Equity (-139.55%) than 77.14% of its industry peers.
Industry RankSector Rank
ROA -30.51%
ROE -139.55%
ROIC N/A
ROA(3y)-13.16%
ROA(5y)-8.64%
ROE(3y)-52.94%
ROE(5y)-33.29%
ROIC(3y)N/A
ROIC(5y)N/A
EVH Yearly ROA, ROE, ROICEVH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • EVH has a worse Gross Margin (21.31%) than 80.00% of its industry peers.
  • In the last couple of years the Gross Margin of EVH has declined.
  • The Profit Margin and Operating Margin are not available for EVH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.09%
GM growth 5Y-2.88%
EVH Yearly Profit, Operating, Gross MarginsEVH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. EVH Health Analysis

2.1 Basic Checks

  • EVH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EVH has less shares outstanding than it did 1 year ago.
  • EVH has more shares outstanding than it did 5 years ago.
  • EVH has a worse debt/assets ratio than last year.
EVH Yearly Shares OutstandingEVH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EVH Yearly Total Debt VS Total AssetsEVH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.19, we must say that EVH is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.19, EVH perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
  • EVH has a debt to FCF ratio of 204.11. This is a negative value and a sign of low solvency as EVH would need 204.11 years to pay back of all of its debts.
  • EVH's Debt to FCF ratio of 204.11 is in line compared to the rest of the industry. EVH outperforms 54.29% of its industry peers.
  • A Debt/Equity ratio of 2.34 is on the high side and indicates that EVH has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.34, EVH is not doing good in the industry: 88.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 204.11
Altman-Z 0.19
ROIC/WACCN/A
WACC6.86%
EVH Yearly LT Debt VS Equity VS FCFEVH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • EVH has a Current Ratio of 1.31. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
  • EVH's Current ratio of 1.31 is on the low side compared to the rest of the industry. EVH is outperformed by 68.57% of its industry peers.
  • EVH has a Quick Ratio of 1.31. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.31, EVH is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
EVH Yearly Current Assets VS Current LiabilitesEVH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EVH Growth Analysis

3.1 Past

  • EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.36%.
  • EVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.75% yearly.
  • EVH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.56%.
  • EVH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.20% yearly.
EPS 1Y (TTM)-86.36%
EPS 3Y-53.75%
EPS 5YN/A
EPS Q2Q%500%
Revenue 1Y (TTM)-26.56%
Revenue growth 3Y11.54%
Revenue growth 5Y15.2%
Sales Q2Q%-27.5%

3.2 Future

  • Based on estimates for the next years, EVH will show a very strong growth in Earnings Per Share. The EPS will grow by 64.70% on average per year.
  • The Revenue is expected to grow by 18.60% on average over the next years. This is quite good.
EPS Next Y201.88%
EPS Next 2Y123.95%
EPS Next 3Y101.54%
EPS Next 5Y64.7%
Revenue Next Year32.56%
Revenue Next 2Y23.92%
Revenue Next 3Y20.2%
Revenue Next 5Y18.6%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EVH Yearly Revenue VS EstimatesEVH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EVH Yearly EPS VS EstimatesEVH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. EVH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 25.89, which means the current valuation is very expensive for EVH.
  • Compared to the rest of the industry, the Price/Earnings ratio of EVH indicates a somewhat cheap valuation: EVH is cheaper than 71.43% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of EVH to the average of the S&P500 Index (26.78), we can say EVH is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 8.58, the valuation of EVH can be described as very reasonable.
  • EVH's Price/Forward Earnings ratio is rather cheap when compared to the industry. EVH is cheaper than 85.71% of the companies in the same industry.
  • EVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.89
Fwd PE 8.58
EVH Price Earnings VS Forward Price EarningsEVH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EVH is valued a bit cheaper than 68.57% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EVH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 54.7
EV/EBITDA 10.4
EVH Per share dataEVH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • EVH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EVH's earnings are expected to grow with 101.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y123.95%
EPS Next 3Y101.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EVH Dividend Analysis

5.1 Amount

  • No dividends for EVH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EVH Fundamentals: All Metrics, Ratios and Statistics

EVOLENT HEALTH INC - A

NYSE:EVH (4/10/2026, 8:19:44 PM)

After market: 2.3435 +0.01 (+0.58%)

2.33

-0.11 (-4.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners110.54%
Inst Owner Change0%
Ins Owners2.06%
Ins Owner Change3.82%
Market Cap260.12M
Revenue(TTM)1.88B
Net Income(TTM)-579.40M
Analysts83
Price Target6.01 (157.94%)
Short Float %16.63%
Short Ratio5.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.5%
Min EPS beat(2)-52.63%
Max EPS beat(2)37.63%
EPS beat(4)1
Avg EPS beat(4)-69.8%
Min EPS beat(4)-226.45%
Max EPS beat(4)37.63%
EPS beat(8)3
Avg EPS beat(8)-80.44%
EPS beat(12)7
Avg EPS beat(12)-19.32%
EPS beat(16)10
Avg EPS beat(16)391.59%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-1.01%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)4
Avg Revenue beat(8)0.35%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)-32.38%
PT rev (3m)-42.11%
EPS NQ rev (1m)-862.7%
EPS NQ rev (3m)-182.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.94%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-4.31%
Revenue NY rev (1m)0.64%
Revenue NY rev (3m)3.63%
Valuation
Industry RankSector Rank
PE 25.89
Fwd PE 8.58
P/S 0.14
P/FCF 54.7
P/OCF 6.7
P/B 0.63
P/tB N/A
EV/EBITDA 10.4
EPS(TTM)0.09
EY3.86%
EPS(NY)0.27
Fwd EY11.66%
FCF(TTM)0.04
FCFY1.83%
OCF(TTM)0.35
OCFY14.93%
SpS16.81
BVpS3.72
TBVpS-7.74
PEG (NY)0.13
PEG (5Y)N/A
Graham Number2.74
Profitability
Industry RankSector Rank
ROA -30.51%
ROE -139.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.31%
FCFM 0.25%
ROA(3y)-13.16%
ROA(5y)-8.64%
ROE(3y)-52.94%
ROE(5y)-33.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.09%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 204.11
Debt/EBITDA 9.25
Cap/Depr 29.42%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion 37.02%
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 0.19
F-Score5
WACC6.86%
ROIC/WACCN/A
Cap/Depr(3y)24.58%
Cap/Depr(5y)37.22%
Cap/Sales(3y)1.42%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.36%
EPS 3Y-53.75%
EPS 5YN/A
EPS Q2Q%500%
EPS Next Y201.88%
EPS Next 2Y123.95%
EPS Next 3Y101.54%
EPS Next 5Y64.7%
Revenue 1Y (TTM)-26.56%
Revenue growth 3Y11.54%
Revenue growth 5Y15.2%
Sales Q2Q%-27.5%
Revenue Next Year32.56%
Revenue Next 2Y23.92%
Revenue Next 3Y20.2%
Revenue Next 5Y18.6%
EBIT growth 1Y-324.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.7%
EBIT Next 3Y28.67%
EBIT Next 5Y21.36%
FCF growth 1Y177.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107%
OCF growth 3YN/A
OCF growth 5YN/A

EVOLENT HEALTH INC - A / EVH Fundamental Analysis FAQ

What is the fundamental rating for EVH stock?

ChartMill assigns a fundamental rating of 3 / 10 to EVH.


Can you provide the valuation status for EVOLENT HEALTH INC - A?

ChartMill assigns a valuation rating of 6 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Fairly Valued.


What is the profitability of EVH stock?

EVOLENT HEALTH INC - A (EVH) has a profitability rating of 1 / 10.


How financially healthy is EVOLENT HEALTH INC - A?

The financial health rating of EVOLENT HEALTH INC - A (EVH) is 2 / 10.


What is the expected EPS growth for EVOLENT HEALTH INC - A (EVH) stock?

The Earnings per Share (EPS) of EVOLENT HEALTH INC - A (EVH) is expected to grow by 201.88% in the next year.